Healey CT, Neilson M, Clark D, Schanzer A, Robinson W, Vascular Study Group of New England. Predicting mortality of ruptured abdominal aortic aneurysms in the era of endovascular repair. Ann Vasc Surg. 2017. 38: 59-63.
Rifas-Shiman SL, Fleisch AF, Hivert MF, Mantzoros C, Gillman MW, Oken E. First and second trimester gestational weight gains are most strongly associated with cord blood levels of hormones at delivery important for glycemic control and somatic growth. Metabolism. 2017. (In press.)
Hakone A, Harrison L, Ottley A, Winters N, Gutheil C, Han PK, Chang R. PROACT: Iterative Design of a Patient-Centered Visualization for Effective Prostate Cancer Health Risk Communication. IEEE Trans Vis Comput Graph. 2017 Jan;23(1):601-610.
Asson-Batres MA, Ryzhov S, Tikhomirov O, Duarte CW, Congdon CB, Lessard CR, McFarland S, Rochette-Egly C, Tran TL, Galindo CL, Favreau-Lessard AJ, Sawyer DB. Effects of vitamin A deficiency in the postnatal mouse heart: role of hepatic retinoid stores. Am J Physiol Heart Circ Physiol. 2016 Jun 1;310(11):H1773-89. doi: 10.1152/ajpheart.00887.2015. Epub 2016 Apr 15.
Gulbrandsen P, Clayman ML, Beach MC, Han PK, Boss EF, Ofstad EH, Elwyn G. Shared decision-making as an existential journey: Aiming for restored autonomous capacity. Patient Educ Couns. 2016 Jul 7. pii: S0738-3991(16)30309-3. doi: 10.1016/j.pec.2016.07.014. [Epub ahead of print]
Trinh QD, Li H, Meyer CP, Hanske J, Choueiri TK, Reznor G, Lipsitz SR, Kibel AS, Han PK, Nguyen PL, Menon M, Sammon JD. Determinants of cancer screening in Asian-Americans. Cancer Causes Control. 2016 Aug;27(8):989-98. doi: 10.1007/s10552-016-0776-8. Epub 2016 Jul 2.
Han PKJ, Piccirillo J, Gutheil C, Williams D, Wartak MM, Dufault C, Hallen S, Lucas FL, Joekes K. Development and evaluation of an online risk communication teaching program for medical student. Med Sci Educator. 2016 Aug. [Epub ahead of print]
Carpenter DM, Geryk LL, Chen AT, Nagler RH, Dieckmann NF, Han PKJ. Conflicting health information: a critical research need. Health Expectations. 2016 (in press).
Duarte CW, Black AW, Lucas FL, Vary CP. Cancer incidence in patients with hereditary hemorrhagic telangiectasia. J Cancer Res Clin Oncol. 2016 Sept 16. [Epub ahead of print] PMID: 27638773.
Biesecker BB, Woolford SW, Klein WMP, Brothers KB, Umstead KL, Lewis KL, Biesecker LG, Han PKJ. PUGS: A novel scale to assess perceptions of uncertainties in genome sequencing. Clinical Genetics. 2016 (in press).
Han PKJ, Umstead KL, Bernhardt BA, Green RC, Joffe S, Koenig B, Krantz I, Waterston LB, Biesecker LG, Biesecker BB. A taxonomy of medical uncertainties in clinical genome sequencing. Genetics in Medicine. 2016 (in press).
Bansback N, Bell M, Spooner L, Pompeo A, Han PKJ, Harrison M. Communicating uncertainty in benefits and harms: a review of patient decision support interventions. The Patient – Patient-Centered Outcomes Research. 30 November 2016. DOI: 10.1007/s40271-016-0210-z. [Epub ahead of print].
Geryk LL, Blalock SJ, DeVellis RF, Jordan JM, Han PKJ, Carpenter DM. Medication information receipt and self-management behaviors among arthritis patients: does attentional coping style matter? Open Rheum J 2016 [Epub ahead of print].
Engelhardt EG, Pieterse AH, Han PKJ, van Duijn-Bakker N, Cluitmans F, Maartense E, Bos MM, Weijl NI, Punt CJA, van Ufford-Mannesse PQ, Sleeboom H, Portielje JEA, van der Hoeven KJM, Woei-A-Jin FJS, Kroep JR, de Haes HCJM, Smets EMA, Stiggelbout AM. Disclosing the uncertainty associated with prognostic estimates in breast cancer: current practices and patients’ perceptions of uncertainty. Med Decis Making. 2016 Sep 28. [Epub ahead of print].
Han PKJ, Joekes K, Mills G, Gutheil C, Smith K, Cochran NE, Elwyn G. Development and evaluation of the “BRISK Scale,” a brief observational measure of risk communication competence. Patient Educ Couns. 2016 Aug 12. [Epub ahead of print].
Fairfield K, and Black, A.“ Geographic variation in cardiovascular risk factors and mortality across the population of Maine and the association with cardiovascular health care utilization: Informing population health efforts to reduce cardiovascular disease in Maine.” Invited presentation at The Dartmouth Institute for Health Policy & Clinical Practice, Lebanon, NH. April 6, 2017.
Korsen, N. The MaineHealth Behavioral Integration Program. The Dartmouth Coop Research Network Annual Meeting. Meredith, NH. January 29, 2017.
Fairfield K, and Black, A. “Geographic variation in cardiovascular risk factors, mortality, and healthcare utilization across Maine: Informing population health efforts to reduce cardiovascular disease” . Poster presentation at the MMCRI Cardiovascular Research Retreat, Scarborough, ME. May 4, 2016.
Han, PKJ. Understanding and communicating uncertainty in health care. Medicine Grand Rounds. Baystate Medical Center. Springfield, MA. November 30, 2016.
Han, PKJ. How can we best present uncertainty that activates patients to make informed decisions? Invited Symposium Panelist. Society for Medical Decision Making 39th Annual Meeting. Vancouver, BC, CA. October 25, 2016.
Han, PKJ. Communicating ambiguity about vaccine effectiveness reduces vaccination intentions: ambiguity aversion and its mechanisms. Society for Medical Decision Making 39th Annual Meeting. Vancouver, BC, CA. October 25, 2016.
Han, PKJ. Developing a meta-tool for implementing clinical prediction models in prostate cancer care. American Urological Association, New England Section 85th Annual Meeting. Portland, ME. September 30, 2016.
Han, PKJ. Training providers in shared decision making and risk communication. Shared Decision Making Summit, Society of Decision Professionals-Society for Medical Decision Making. New Paltz, NY. September 28, 2016.
Hutchinson RN, Becker M, Lucas L, Weirman H, Fairfield K. Hospice Care and Length of Stay in Hospice for Patients Dying with Melanoma. Poster presented at the Society of General Internal Medicine annual meeting: May 11-14, 2016, Hollywood, FL. Presentation awarded SGIM’s 2016 Best Poster Award!
Korsen, N. et al. A central structure working locally – description of MaineHealth’s Behavioral Health Integration Program. Collaborative Family Healthcare Association Annual Meeting. Charlotte, NC. October 13-15, 2016.
Korsen, N. & Pomerantz, A. Key Principles for Making Integration Successful Across Settings. Collaborative Family Healthcare Association Annual Meeting. Charlotte, NC. October 13-15, 2016.
Korsen, N. et al. Experiences using the AHRQ Integration Playbook. Collaborative Family Healthcare Association Annual Meeting. Charlotte, NC. October 13-15, 2016.
Waterston, LB. The Maine Lung Cancer Prevention and Screening Initiative. Invited Lecture: Tufts University School of Medicine, Department of Public Health & Community Medicine, “Online Consumer Health” course. Boston, MA. November 7, 2016.
View Dr. Paul Han’s Everyday Health Article on “Prostate Cancer Screening”
Part of the issue may be the short time frame of many appointments, says Paul Han, MD, senior scientist at Maine Medical Center Research Institute in Scarborough. “Even well-intentioned doctors are finding it tough to take the time in a 10-minute office visit” to include shared decision-making regarding the PSA test. Shared decision-making is not reimbursed either, says Dr. Han.
View Dr. Paul Han’s Sun Journal Article “Work together to cut rate of lung cancer”
Lung Cancer Awareness Month (November) has passed, but it is still a good time to reflect upon the magnitude and impact of this disease. Lung cancer is the No. 1 cancer killer of men and women in the U.S., and its toll in Maine is tremendous. Our state has the sixth highest lung cancer incidence rate in the nation.
View Channel 8 Interview with Paul Han on evaluating the benefits of PSA testing for prostate cancer screening:
September is Prostate Cancer Awareness Month and as part of our ongoing partnership with the Maine Cancer Foundation, WMTW News 8 met with experts to help explain the confusion around a particular prostate test.
View Paul Han authored a guest blog on the Maine Cancer Foundation website for Prostate Cancer Awareness Month
Prostate cancer is the most common cancer and the third leading cause of cancer deaths among US men. The prostate-specific antigen (PSA) test is a blood test used to “screen” for prostate cancer—that is, to detect cancer at an early stage, when it can be effectively treated. PSA testing is currently the only available screening test for prostate cancer, and for many years it has been widely used.
View Tufts Medicine Article
Alexa Craig, a neonatal and pediatric neurologist, and Teresa May, a pulmonary and neurocritical care specialist, are the first Maine Medical Center faculty members funded through the Tufts Clinical and Translational Science Institute (CTSI) career development program.
They have been awarded KL2 awards (of around $325,000 each)—only about 15 percent of applicants receive funding, which comes from the National Institutes of Health. Beyond research, the grants fund Sackler School coursework, training, mentoring and seminars, explained Karen Freund, professor at the School of Medicine and KL2 program director. “These are the resources to really launch careers.”
View the New York Times Article
There was no reason for the patients to receive vitamin D tests. They did not have osteoporosis; their bones were not cracking from a lack of the vitamin. They did not have diseases that interfere with vitamin D absorption.
Yet in a recent sample of 800,000 patients in Maine, nearly one in five had had at least one test for blood levels of the vitamin over a three-year period. More than a third got two or more tests, often to evaluate such ill-defined complaints as malaise or fatigue.
The researchers who gathered the data, Dr. Kathleen Fairfield and Kim Murray of the Maine Medical Center, were surprised. Perhaps they shouldn’t have been.
Millions of people are popping supplements in the belief that vitamin D can help turn back depression, fatigue, muscle weakness, even heart disease or cancer. In fact, there has never been widely accepted evidence that vitamin D is helpful in preventing or treating any of those conditions
View news segment
The Bristol-Myers Squibb Foundation has awarded a $5 million grant to Maine Medical Center (MMC) for the creation of a statewide initiative to improve the prevention, early detection and treatment of lung cancer in Maine, where incidence rates and deaths due to lung cancer are among the highest in the nation, according to the Centers for Disease Control and Prevention.
Maine LungCAPS Initiative Principal Investigator Paul Han, MD, MA, MPH, director of the Center for Outcomes Research and Evaluation at the MMC Research Institute said, “The Maine LungCAPS Initiative will develop the infrastructure and inter-institutional collaboration required to expand access to evidence-based lung cancer prevention and screening services, and to facilitate earlier and more effective treatment of lung cancer for patients across the state.”
View Portland Press Herald article
Dr. Paul Han of Maine Med says key to the effort will be coordinating the work of several groups or institutions, including Maine General Medical Center, the American Lung Association of Maine, and others.
“Institutions and partners who don’t always work together, actually, and who bring different skills and areas of expertise and strengths and so forth, to kind of work together in a coordinated fashion to attack the problem of lung cancer in Maine,” Han says.
An Interview with Dr. Paul Han
Paul Han, MD, MA, MPH, director of the Center for Outcomes Research and Evaluation at the MMC Research Institute, is the Principal Investigator for the recently announced Maine LungCAPS initiative, a program designed to improve the prevention, early detection and treatment of lung cancer in Maine.
View Maine Cancer Foundation interview with Dr. Paul Han
WMTW-TV (Channel 8/ABC) spoke with Dr. Paul Han of MMCRI and CORE and Dr. Mayuko Fukunaga of Chest Medicine Associates about how a research grant from the Maine Cancer Foundation will aid in earlier detection of lung cancer and better shared decision-making about screenings with patients.
View news segment
New Grant Funding
NIH Northern New England Clinical & Translational Research Network (NNE-CTR): Rural Health Research & Delivery Core (Neil Korsen, MD) & Clinical Research Design, Epidemiology & Biostatistics Core (Susan Santangelo, ScD)
Bristol Myers Squibb Foundation, Maine Cancer Foundation, and Maine Economic Improvement Foundation: Maine Lung Cancer Coalition: “A statewide initiative to improve the prevention, early detection and treatment of lung cancer in Maine.” (Paul Han, MD)
Jackson Laboratory and Harold Alfond Foundation: Maine Cancer Genomics Initiative (MCGI): “Implement tumor genomic profiling and cancer precision medicine for all Maine cancer patients.” (Paul Han, MD)
MMC Medical Education Innovations: “Developing a Toolkit for Residency and Fellowship Directors for Shared Decision Making in Graduate Medical Education.” (Kathleen Fairfield, MD)
Administration for Community Living, Southern Maine Agency on Aging (SMAA): “Evidence-Based Falls Prevention Program.” (Neil Korsen, MD)
National Science Foundation-Center for Health Organization Transformation (CHOT): “System Analysis of Graduate Medical Education Processes.” (Jim Benneyan, PhD-PI, Collaborative NEU/MMC project)
Accreditation Council for Graduate Medical Education (ACGME) CLER Pathway Innovators: “Redesigning the Clinical Learning Environment to Improve Interprofessional Care and Education.” (Thomas Van der Kloot, MD-PI, Paul Han, MD, Jordan Peck, PhD, Collaborative NEU/MMC project)